ArticleTranslational lung cancer research2026
Robotic subxiphoid-optical thymectomy for Good's syndrome in a severely immunocompromised patient: a case report.
Article in Translational lung cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Good's syndrome is a rare adult-onset immunodeficiency characterized by thymoma and hypogammaglobulinemia. The optimal surgical approach for thymoma in patients with severe immunodeficiency remains undefined. In this report, we describe a case of Good's syndrome in an elderly male patient with severe hypogammaglobulinemia, who underwent robotic subxiphoid-optical thymectomy as part of a perioperative strategy aimed at reducing surgical invasiveness. Case Description: An 80-year-old man with Good's syndrome presented with hypogammaglobulinemia (serum IgG, 60 mg/dL), complete absence of B cells, and a 5.5-cm anterior mediastinal tumor. Given this pronounced immunodeficiency, robotic subxiphoid-optical thymectomy was indicated to minimize surgical trauma while avoiding median sternotomy. The perioperative management strategy included preoperative intravenous immunoglobulin (IVIG) replacement therapy, extended antibiotic prophylaxis, careful patient selection, and close perioperative monitoring. Complete (R0) resection was achieved, and pathologic examination demonstrated type AB thymoma, Masaoka-Koga stage II. No perioperative infectious complications occurred, allowing timely initiation of cyclosporine when pure red cell aplasia developed eight weeks postoperatively, followed by partial hematologic recovery. Monthly IVIG replacement was continued, and no further infectious complications or thymoma recurrence were observed during 24 months of follow-up. Conclusions: This case suggests that robotic subxiphoid-optical thymectomy could be an option in selected patients with Good's syndrome and severe immunodeficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.